Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure enables effective binding in targeted drug designs, especially in oncology and inflammatory disease research. The presence of both bromine and trifluoroethanol groups allows for further functionalization through cross-coupling reactions, making it valuable in medicinal chemistry for building complex molecules. Also employed in agrochemical research for developing new active ingredients with improved metabolic stability and selectivity.